Literature DB >> 7726615

Preventative policies in transfusion associated graft versus host disease in the treatment of cancer.

D K Webb1.   

Abstract

Experience of transfusion associated graft versus host disease (TA-GvHD) and current preventative policy in 22 UK children's cancer centres was established by questionnaire. Cellular blood products were irradiated in all centres during bone marrow transplantation, but there was no consensus for children receiving standard chemotherapy. Irradiation dose varied from 1500-5000 cGy and was below 2500 cGy in 12 units. Five cases of TA-GvHD were identified; all five children died.

Entities:  

Mesh：

Year:  1994        PMID： 7726615      PMCID： PMC1030093          DOI： 10.1136/adc.71.6.532

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

Review 1.  Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease.

Authors:  K C Anderson; L T Goodnough; M Sayers; P T Pisciotto; S R Kurtz; T A Lane; C S Anderson; L E Silberstein
Journal:  Blood       Date:  1991-05-15       Impact factor: 22.113

Review 2.  Transfusion-associated graft-versus-host disease and blood irradiation.

Authors:  J V Linden; P T Pisciotto
Journal:  Transfus Med Rev       Date:  1992-04

Review 3.  Transfusion-associated graft-versus-host disease: historical perspectives, incidence, and current use of irradiated blood products.

Authors:  B H Greenbaum
Journal:  J Clin Oncol       Date:  1991-10       Impact factor: 44.544

4.  Graft-versus-host reaction following blood product transfusion.

Authors:  V von Fliedner; D J Higby; U Kim
Journal:  Am J Med       Date:  1982-06       Impact factor: 4.965
  4 in total
  1 in total

Review 1.  Irradiation in the prevention of transfusion associated graft-versus-host disease.

Authors:  D K Webb
Journal:  Arch Dis Child       Date:  1995-11       Impact factor: 3.791
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.